← FDA Drug Approvals (Drugs@FDA)

BRYTLY

NDA · New Drug Application · Sponsor: ALCON LABORATORIES, INC. · Approved 2026-10-16

Drug application

FDA Application #

NDA220341

Application type

New Drug Application

Brand name

BRYTLY

Generic name

Brytly (Apraclonidine)

Active ingredients

BRYTLY (APRACLONIDINE)

Dosage form

SOLUTION/ DROPS

Route

—

Marketing status

Prescription

Sponsor

ALCON LABORATORIES, INC.

First approval

2026-10-16

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown